Merge Hemo, Software packages 10.2, 10.3, and 10.4
FDA Device Recall #Z-2387-2021 — Class II — July 23, 2021
Recall Summary
| Recall Number | Z-2387-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | July 23, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Merge Healthcare, Inc. |
| Location | Hartland, WI |
| Product Type | Devices |
| Quantity | 326 units |
Product Description
Merge Hemo, Software packages 10.2, 10.3, and 10.4
Reason for Recall
The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.
Distribution Pattern
US distribution
Lot / Code Information
Version 10.2, UDI (01)00842000100430(10)10.2(11)190612 Version 10.3, UDI (01)00842000100874(10)10.3(11)200330 Version 10.4, UDI (01)00842000100966(10)10.4(11)210428
Other Recalls from Merge Healthcare, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2518-2025 | Class II | Merge Hemo, Model RCSV2, Model/Catalog Number 9... | Aug 11, 2025 |
| Z-1399-2025 | Class II | VERICIS, Merge Cardio, Model/Catalog Number: Ve... | Feb 19, 2025 |
| Z-1402-2025 | Class II | Merge Cardio, Model/Catalog Number: Version 12.... | Feb 19, 2025 |
| Z-1401-2025 | Class II | VERICIS, Merge Cardio, Model/Catalog Number: Ve... | Feb 19, 2025 |
| Z-1398-2025 | Class II | VERICIS, Merge Cardio, Model/Catalog Number: Ve... | Feb 19, 2025 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.